Get the Stockscreener App
73.69
0.50%
0.37
Pre-market:
73.79
0.10
+0.14%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $73.69, with a volume of 4.99M.
It is up +0.50% in the last 24 hours and up +19.92% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health adds primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$73.32
Open:
$73.42
24h Volume:
4.99M
Relative Volume:
0.70
Market Cap:
$93.46B
Revenue:
$386.46B
Net Income/Loss:
$4.49B
P/E Ratio:
20.58
EPS:
3.58
Net Cash Flow:
$4.78B
1W Performance:
+2.15%
1M Performance:
+19.92%
6M Performance:
+14.76%
1Y Performance:
+24.27%
1-Day Range:
$72.91
$73.91
1-Week Range:
$72.16
$74.53
52-Week Range:
$43.56
$74.53
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
73.69 | 93.97B | 386.46B | 4.49B | 4.78B | 3.58 |
|
UNH
Unitedhealth Group Inc
|
310.38 | 279.67B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CI
Cigna Group
|
304.03 | 80.27B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
308.05 | 72.58B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
312.00 | 37.29B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
Panagora Asset Management Inc. Raises Stock Holdings in CVS Health Corporation $CVS - MarketBeat
OMERS ADMINISTRATION Corp Sells 7,705 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Canada Pension Plan Investment Board - MarketBeat
CVS Caremark’s Boosting of Wegovy Over Zepbound Fuels Lawsuits - Bloomberg Law News
Key metrics from CVS Health Corporation’s quarterly dataWeekly Trend Recap & Long-Term Safe Investment Plans - Newser
CVS Health Corporation $CVS Shares Sold by Chiron Capital Management LLC - MarketBeat
Is CVS Health Stock Outperforming The Dow? - Barchart.com
Risk adjusted return profile for CVS Health Corporation analyzedEarnings Overview Summary & Low Volatility Stock Suggestions - Newser
Caisse DE Depot ET Placement DU Quebec Reduces Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation (NYSE:CVS) Given Average Rating of "Buy" by Brokerages - MarketBeat
CVS Caremark Faces Lawsuit for Favoring Wegovy Over Zepbound (1) - Bloomberg Law News
10 Top-Performing Dividend Stocks - Morningstar
Lansforsakringar Fondforvaltning AB publ Sells 11,537 Shares of CVS Health Corporation $CVS - MarketBeat
Can CVS Health Corporation rally from current levelsPortfolio Risk Summary & Technical Pattern Alert System - Newser
63% of Americans Plan Flu Shots: CVS Health Expands with 3-in-1 Testing in 38 States for 2025-2026 - Stock Titan
Te Ahumairangi Investment Management Ltd Trims Position in CVS Health Corporation $CVS - MarketBeat
Volatility clustering patterns for CVS Health Corporation2025 Risk Factors & Weekly Setup with ROI Potential - Newser
Is CVS Health Corporation forming a double bottomJuly 2025 Breakouts & Growth Focused Stock Reports - khodrobank.com
How high can CVS Health Corporation stock goWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - Newser
CVS Health Corporation $CVS Shares Sold by Rafferty Asset Management LLC - MarketBeat
Ieq Capital LLC Purchases 180,495 Shares of CVS Health Corporation $CVS - MarketBeat
Cvs Health stock hits 52-week high at 73.26 USD - Investing.com
Former CVS CFO Guertin joins board of Aledade, largest US primary care networkProvidence Business First - The Business Journals
Price momentum metrics for CVS Health Corporation explained2025 Dividend Review & Growth-Oriented Investment Plans - Newser
CVS, Walgreens Limit COVID Vaccines in Some States as Rules Shift - The Herald Palladium
CVS Health Sees Momentum in HCB Segment Amid Utilization Pressure - sharewise.com
CVS Health Sees Momentum In HCB Segment Amid Utilization Pressure - Barchart.com
Cvs Health stock hits 52-week high at 73.26 USD By Investing.com - Investing.com Australia
3,698 Shares in CVS Health Corporation $CVS Bought by Connecticut Wealth Management LLC - MarketBeat
CVS agrees to pay Massachusetts $12M to settle Medicaid overbilling claims - Yahoo Finance
Guggenheim Capital LLC Trims Stock Position in CVS Health Corporation $CVS - MarketBeat
Landscape Capital Management L.L.C. Cuts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
290,000 Shares in CVS Health Corporation $CVS Purchased by Callodine Capital Management LP - MarketBeat
Gamco Investors INC. ET AL Sells 8,857 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Evergreen Capital Management LLC - MarketBeat
Is CVS Health Corporation’s ROIC above industry averageJuly 2025 Rallies & Verified Entry Point Signals - khodrobank.com
Trexquant Investment LP Acquires 97,097 Shares of CVS Health Corporation $CVS - MarketBeat
Understanding CVS Health Corporation’s price movementWeekly Trade Analysis & Accurate Buy Signal Alerts - Newser
Gabelli Funds LLC Sells 28,500 Shares of CVS Health Corporation $CVS - MarketBeat
Advanced analytics toolkit walkthrough for CVS Health CorporationTrade Signal Summary & AI Forecasted Entry/Exit Points - Newser
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
4.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):